Servicios profesionales farmacéuticos asistenciales. A propósito de un caso
- S. Dévora Gutiérrez 1
- C. Morales Marrero
- P. Herrera Ramos 2
- A. Vera Peña 1
- A. Oliva Martin 3
- S. Abdala Kuri 1
- 1 Departamento de Medicina Física y Farmacología, Facultad Farmacia, Universidad La Laguna
- 2 Centro de Salud Finca España. San Cristóbal de La Laguna
- 3 Departamento de Ingeniería Química y Tecnología Farmacéutica, Facultad Farmacia, Universidad La Laguna
ISSN: 1885-8619
Year of publication: 2024
Volume: 16
Issue: 4
Type: Article
More publications in: Farmacéuticos comunitarios
Abstract
Case presentation: A 73-year-old woman, independent, with a medical history of psychopathology under treatment and non-compliant. After a fall, he suffered a forearm fracture and, in this context, abuse of psychoactive drugs and non-steroidal antiinflammatory drugs was suspected. Study and evaluation of the case: The state of the patient’s situation was evaluated, and an abuse of the hypnotic-anxiolytic treatment was observed, which could be related to her recent forearm fracture. His poor therapeutic adherence led to poor control of his health problems and the appearance of possible Negative Outcomes Associated with Medication (NOM). Intervention: He was referred to his primary care physician with a pharmacist consultation report, indicating the possible NMRs and therapeutic alternatives in antihypertensive and antidepressant treatment. Results: The family physician related the fall and subsequent forearm fracture, as well as the decompensation of his basal pathology, with therapeutic noncompliance. The proposal for pharmaceutical intervention was accepted, monitoring blood pressure for its corresponding dosage readjustment, bupropion was withdrawn, a gradual deprescription of benzodiazepine doses began, and the antiinflammatory was replaced by analgesics. Consequently, the patient significantly improved her cardiovascular health and her quality of life, in addition to increasing her personal autonomy. Conclusions: Multidisciplinary communication between health professionals allows better control of cardiovascular disease and optimization of pharmacotherapy and health resources, contributing to improving their state of health.
Bibliographic References
- Cremades J, Bellver S, García J, Velasco J, Arranz M, Baixauli B, Alonso M. Proyecto revisa®. ¿Sirve realmente para algo la revisión de la medicación?. Farm Comunitarios. 2022 Jun 15;14(Supl 1. Congreso SEFAC):233. doi:10.33620/FC.2173-9218.(2022).CMC.246.
- EuroQol Research Foundation. EQ-5D-3L User Guide, 2018. Consultado: 14 noviembre 2022) Disponible en: https://euroqol.org/publications/user-guides.
- Martín Oliveros A, Aliaga Gutiérrez L, Abadías Guasch M, Iracheta Todó M, Olmo Quintana V. Documento de consenso sobre el uso de los sistemas personalizados de dosificación (SPD). Ed. SEFAC-SEMERGEN. Madrid, 2020. Disponible en https://www.sefac.org/system/files/2021-11/SPD_CONSENSO.pdf.
- Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personal y Garantía de derechos digitales. BOE 294 de 06/12/2018. https://www.boe.es/eli/es/lo/2018/12/05/3/con.
- Centro de Información de Medicamentos (CIMA) de la Agencia Española de Medicamentos y Productos Sanitarios. (Consultado: 14 noviembre 2022) Disponible en https://cima.aemps.es/cima/doc.html/ft/64929/FT_64929.html.
- Martín A, Lozano M, Ferrer E. Deshabituación de benzodiazepinas en un paciente preparando cápsulas de diazepam en dosis decrecientes. Farmacéuticos Comunitarios. 2020 May 11;12(2):26-29. doi:10.33620/FC.2173-9218.(2020/Vol12).002.05
- Dévora S, Morales C, Oliva M, Abdala S. Atención multidisciplinar: farmacia comunitaria y medicina familiar. Farm Com.2022;14(4):4248. doi:10.33620/FC.2173-9218.(2022/Vol14).004.07.